Source: Eur Respir J 2014; 43: 20-23



Rating:

Share or cite this content

Citations should be made in the following way:
Castellani Carlo, Massie John. Newborn screening and carrier screening for cystic fibrosis: alternative or complementary?. Eur Respir J 2014; 43: 20-23

Member's Comments

No comment yet.

Related content which might interest you: Newborn screening for cystic fibrosis: opportunities and remaining challenges Source: Eur Respir Monogr 2014; 64: 65-76 Year: 2014 Should the D1152H variant be included in cystic fibrosis newborn screening programmes? Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 1-PRO "Newborn screening for cystic fibrosis should be added to routine newborn screening programmes" Source: Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma Year: 2010 Newborn screening in Europe Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening Year: 2006 Newborn screening for cystic fibrosis: pros and cons Source: Breathe 2011; 8: 24-30 Year: 2011 Newborn cystic fibrosis (CF) screening: influence of data transformation and density estimation on newborn recall Source: Eur Respir J 2007; 30: Suppl. 51, 30s Year: 2007 Is newborn screening for cystic fibrosis cost-effective? Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine Year: 2010 Revisiting α1-antitrypsin therapy in cystic fibrosis: can it still offer promise? Source: Eur Respir J 2007; 29: 229-230 Year: 2007 A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 Newborn screening for cystic fibrosis - lessons from national programmes in Europe Source: International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children Year: 2018 Characteristics of cystic fibrosis patients diagnosed after false negative cystic fibrosis newborn screening results Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019 Cystic fibrosis newborn screening for R117H in England Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 Health-economic aspects of cystic fibrosis screening and therapy Source: Eur Respir Monogr 2014; 64: 304-319 Year: 2014 The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Newborn screening for cystic fibrosis in Spain Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Early diagnosis from newborn screening maximises survival in severe cystic fibrosis Source: ERJ Open Res, 4 (2) 00109-2017; 10.1183/23120541.00109-2017 Year: 2018 Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Genomically-guided therapies: a new era for cystic fibrosis Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases Year: 2020